Prevalence of hereditary hemochromatosis in 16 031 primary care patients

Annals of Internal Medicine

Volumn 129, Issue 11, 1998, Pages 954-961

  Phatak, Pradyumna D ^a,b   Sham, Ronald L ^a,b   Raubertas, Richard F ^a,c   Dunnigan, Karin ^a,b   O'Leary, Mary Teresa ^a,b   Braggins, Caroline ^a,b   Cappuccio, Joseph D ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b ROCHESTER GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; FEMALE; HEMOCHROMATOSIS; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SCREENING;

EID: 0032401707     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-11_part_2-199812011-00006     Document Type: Article

References (27)

1. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med. 1993;328:1616-20.
2. Baer DM, Simons JL, Staples RL, Rumore GJ, Morton CJ. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med. 1995;98:464-8.
3. Balan V, Baldus W, Fairbanks V, Michels V, Burritt M, Klee G. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients. Gastroenterology. 1994;107:453-9.
4. Edwards CQ, Griffin LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 1988;318:1355-62.
5. Iron overload disorders among Hispanics - San Diego, California, 1995. MMWR Morb Mortal Wkly Rep. 1996;45:991-3.
6. Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen. 1996;3:178-84.
7. Looker AC, Johnson CL. Prevalence of elevated serum transferrin saturation in adults in the United States. Ann Intern Med. 1998;129:940-5.
8. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
9. Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA. 1998;280:172-8.
10. Borwein ST, Ghent CN, Flanagan PR, Chamberlain MJ, Valberg LS. Genetic and phenotypic expression of hemochromatosis in Canadians. Clin Invest Med. 1983;6:171-9.
11. Olsson KS, Ritter B, Rosen U, Heedman PA, Staugard F. Prevalence of iron overload in Central Sweden. Acta Med Scand. 1983;213:145-50.
12. Hallberg L, Bjorn-Rasmussen E, Jungner I. Prevalence of hereditary hemochromatosis in two Swedish urban areas. J Intern Med. 1989;225:249-55.
13. Elliott R, Lin BP, Dent OF, Tait A, Smith CI. Prevalence of hemochromatosis in a random sample of asymptomatic men. Aust N Z J Med. 1986;16:491-5.
14. Tanner AR, Desai S, Lu W, Wright R. Screening for hemochromatosis in the UK: preliminary results [Abstract]. Gut. 1985;26:A1139-40.
15. Summary of a report on assessment of the iron nutritional status of the United States population. Expert Scientific Working Group. Am J Clin Nutr. 1985;42:1318-30.
16. Meyer T, Baynes R, Bothwell T, Jenkins T, Jooste P, Du Toit E, et al. Phenotypic expression of the HLA linked iron-loading gene in males over the age of 40 years: a population study using serial serum ferritin estimations. J Intern Med. 1990;227:397-406.
17. Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol. 1990;74:525-30.
18. Lindmark B, Eriksson S. Prevalence of hemochromatosis [Letter]. N Engl J Med. 1988;319:1548-9.
19. Cox DR, Oakes D. Analysis of Survival Data. New York: Chapman and Hall; 1984.
20. Thomas DR, Grunkemeier GL. Confidence interval estimation of survival probabilities for censored data. Journal of the American Statistical Association. 1975;70:865-71.
21. Phatak PD, Guzman G, Woll JE, Robeson A, Phelps CE. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med. 1994; 154:769-76.
22. Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology. 1984;87:628-33.
23. Borwein S, Ghent CN, Valberg LS. Diagnostic efficacy of screening tests for hereditary hemochromatosis. Can Med Assoc J. 1984;131:895-901.
24. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 1986;6:24-9.
25. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis. 1996; 22:187-94.
26. Gordeuk V, Mukiibi J, Hasstedt SJ, Samowitz W, Edwards CQ, West G, et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med. 1992;326:95-100.
27. Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL. Iron overload in African Americans. Am J Med. 1995;99:616-23.